Adi Zundelevich

1.1k total citations
13 papers, 701 citations indexed

About

Adi Zundelevich is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Adi Zundelevich has authored 13 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Adi Zundelevich's work include Epigenetics and DNA Methylation (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Adi Zundelevich is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Adi Zundelevich collaborates with scholars based in Israel, United States and Mali. Adi Zundelevich's co-authors include Einav Nili Gal‐Yam, Varda Rotter, Alina Molchadsky, Naomi Goldfinger, Micha Ilan, Boáz Lazar, Yoel Kloog, Netta Mendelson Cohen, Shirley Horn‐Saban and Zohar Mukamel and has published in prestigious journals such as Nature Genetics, Cancer Research and Cell Death and Differentiation.

In The Last Decade

Adi Zundelevich

13 papers receiving 693 citations

Peers

Countries citing papers authored by Adi Zundelevich

Since Specialization

Citations

This map shows the geographic impact of Adi Zundelevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Zundelevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Zundelevich more than expected).

Fields of papers citing papers by Adi Zundelevich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi Zundelevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Zundelevich. The network helps show where Adi Zundelevich may publish in the future.

Co-authorship network of co-authors of Adi Zundelevich

This figure shows the co-authorship network connecting the top 25 collaborators of Adi Zundelevich. A scholar is included among the top collaborators of Adi Zundelevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi Zundelevich. Adi Zundelevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation 2024 ·Cells ·Rakefet Ben-Yishay, (unknown), Nora Balint‐Lahat, (unknown), (unknown), Vered Bar, (unknown), (unknown), Adi Zundelevich, Raanan Berger, Dana Ishay-Ronen	2
2	Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer 2022 ·Biomedicines ·(unknown), Galit Horn, (unknown), Tova Waks, Ido Laskov, Nadav Michaan, Yael Raz, Vered Bar, Adi Zundelevich, (unknown), (unknown), Giuseppe Mallel, Seth J. Salpeter, (unknown), (unknown), Ben‐Zion Katz, Dan Grisaru, Anat Globerson Levin	9
3	ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis 2020 ·Breast Cancer Research ·Adi Zundelevich, Maya Dadiani, (unknown), (unknown), Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, (unknown), Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam	67
4	Abstract 657: ESR1 mutations abundance in local recurrence of endocrine-treated breast cancer 2018 ·Cancer Research ·Adi Zundelevich, Maya Dadiani, (unknown), Moran Gadot, (unknown), (unknown), (unknown), (unknown), Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam	1
5	Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis 2016 ·Neoplasia ·(unknown), Keren Bahar‐Shany, (unknown), Yishay Pinto, (unknown), (unknown), Chen Dor, (unknown), Iris Barshack, Adi Zundelevich, Einav Nili Gal‐Yam, Yuval Yung, Ariel Hourvitz, Jacob Korach, Mario Beiner, (unknown), Erez Y. Levanon, Michal Barák, Sarit Aviel‐Ronen, Keren Levanon	21
6	Chromatin-Modifying Agents Reactivate Embryonic Renal Stem/Progenitor Genes in Human Adult Kidney Epithelial Cells but Abrogate Dedifferentiation and Stemness 2013 ·Cellular Reprogramming ·Dorit Omer, Orit Harari‐Steinberg, Ella Buzhor, Sally Metsuyanim, Oren Pleniceanu, Adi Zundelevich, Einav Nili Gal‐Yam, Benjamin Dekel	9
7	Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues 2012 ·Nature Genetics ·Gilad Landan, Netta Mendelson Cohen, Zohar Mukamel, Amir Bar, Alina Molchadsky, Ran Brosh, Shirley Horn‐Saban, (unknown), Naomi Goldfinger, Adi Zundelevich, Einav Nili Gal‐Yam, Varda Rotter, Amos Tanay	205
8	Epigenetic silencing of the tumor suppressor klotho in human breast cancer 2011 ·Breast Cancer Research and Treatment ·Tamar Rubinek, (unknown), (unknown), Shikha Bose, Ayelet Avraham, Adi Zundelevich, Ella Evron, Einav Nili Gal‐Yam, Bella Kaufman, Ido Wolf	88
9	Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells 2010 ·Cell Death and Differentiation ·Ira Kogan-Sakin, Yuval Tabach, (unknown), Alina Molchadsky, Hilla Solomon, Shalom Madar, Iris Kamer, Perry Stambolsky, (unknown), Naomi Goldfinger, Sandrine Valsesia‐Wittmann, Alain Puisieux, Adi Zundelevich, Einav Nili Gal‐Yam, Camilla Avivi, Iris Barshack, Mariana Brait, David Sidransky, Eytan Domany, Varda Rotter	130
10	Synthesis of a Novel Macrocyclic Library: Discovery of an IGF-1R Inhibitor 2008 ·Journal of Combinatorial Chemistry ·Nir Qvit, Hadas Reuveni, (unknown), Adi Zundelevich, Galia Blum, Masha Y. Niv, (unknown), (unknown), Deborah E. Shalev, Assaf Friedler, Chaim Gilon	15
11	Gene Expression Signature of Human Cancer Cell Lines Treated with the Ras Inhibitor Salirasib ( S -Farnesylthiosalicylic Acid) 2007 ·Cancer Research ·Roy Blum, Ran Elkon, (unknown), Adi Zundelevich, Jasmine Jacob‐Hirsch, Gideon Rechavi, Ron Shamir, Yoel Kloog	40
12	Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid) 2007 ·Molecular Cancer Therapeutics ·Adi Zundelevich, Galit Elad‐Sfadia, Ronit Haklai, Yoel Kloog	50
13	Chemicalversusmechanical bioerosion of coral reefs by boring sponges - lessons fromPione cf. vastifica 2006 ·Journal of Experimental Biology ·Adi Zundelevich, Boáz Lazar, Micha Ilan	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact